Ghent University Academic Bibliography

Journal Article
A1
open access

Expert consensus on surgical management of primary diffuse type 2‐dominant chronic rhinosinusitis

Manon Blauwblomme (UGent) , Christos Georgalas, Shahzada Ahmed, Isam Alobid, Paolo Battaglia, Paolo Castelnuovo, Jannis Constantinidis, Iacopo Dallan, Anne‐Sophie Eeckels, Marco Ferrari, et al.

(2025) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 15(3). p.303-316

Add to list

Journal Article
A1
open access

EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care

Peter Hellings (UGent) , Isam Alobid, Wilma T. Anselmo‐Lima, Manuel Bernal‐Sprekelsen, Leif Bjermer, Lisa Caulley, Adam Chaker, Jannis Constantinidis, Diego M. Conti, Eugenio De Corso, et al.

(2024) ALLERGY. 79(5). p.1123-1133

Add to list

European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis

Philippe Gevaert (UGent) , Jarno De Craemer (UGent) , Claus Bachert (UGent) , Manon Blauwblomme (UGent) , Adam Chaker, Cemal Cingi, Peter Hellings (UGent) , Claire Hopkins, Valérie Hox, Wytske J. Fokkens, et al.

(2023) ALLERGY. 78(4). p.912-922

Add to list

Chronic rhinosinusitis outcome registry (CHRINOSOR) : establishment of an international outcome registry driven by mHealth technology

Sven F. Seys, Peter Hellings (UGent) , Isam Alobid, Vibeke Backer, Emilie Bequignon, Christian von Buchwald, Carlo Cavaliere, André Coste, Lauren Deneyer, Zuzana Diamant, et al.

(2023) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 11(2). p.431-438.e2

Add to list

Omalizumab improves quality of life in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma

Jonathan Corren, Claus Bachert (UGent) , Philippe Gevaert (UGent) , Joaquim Mullol, Joseph Han, Randall Ow, Sanna Toppila-Salmi, Isam Alobid, Derrick Kaufman, Jessica Braid, et al.

(2020) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 145(2). p.AB250-AB250

Add to list

Journal Article
A1
open access

COVID-19 and olfactory dysfunction : an ENT perspective to the current COVID-19 pandemic

Anneclaire V. Vroegop, Anne-Sophie Eeckels (UGent) , Vincent Van Rompaey, Dirk Vanden Abeele, Michele Schiappoli, Isam Alobid, Thomas Hummel, Clotilde De Dorlodot, Patrick Levie, Caroline Huart, et al.

(2020) B-ENT. 16(1). p.81-85

Add to list

Omalizumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of asthma status

Claus Bachert (UGent) , Philippe Gevaert (UGent) , Jonathan Corren, Joaquim Mullol, Joseph Han, Randall Ow, Sanna Toppila-Salmi, Isam Alobid, Derrick Kaufman, Bongin Yoo, et al.

(2020) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 145(2). p.AB149-AB149

Add to list

Journal Article
A1
open access

Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis : an EAACI position paper

Valerie Hox, Evelijn Lourijsen, Arnout Jordens, Kristian Aasbjerg, Ioana Agache, Isam Alobid, Claus Bachert (UGent) , Koen Boussery (UGent) , Paloma Campo, Wytske Fokkens, et al.

(2020) CLINICAL AND TRANSLATIONAL ALLERGY. 10(1).

Add to list

Miscellaneous
open access

Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis : an EAACI position paper (vol 10, 1, 2020)

Valerie Hox, Evelijn Lourijsen, Arnout Jordens, Kristian Aasbjerg, Ioana Agache, Isam Alobid, Claus Bachert (UGent) , Koen Boussery (UGent) , Paloma Campo, Wytske Fokkens, et al.

(2020) CLINICAL AND TRANSLATIONAL ALLERGY. 10(1).

Add to list

Journal Article
A1
open access

Real-life assessment of chronic rhinosinusitis patients using mobile technology : the mySinusitisCoach project by EUFOREA

Sven F. Seys, Shana De Bont, Wytske J. Fokkens, Claus Bachert (UGent) , Isam Alobid, Manuel Bernal-Sprekelsen, Leif Bjermer, Ina Callebaut, Lars-Olaf Cardell, Sean Carrie, et al.

(2020) ALLERGY. 75(11). p.2867-2878

Academic Bibliography

Expert consensus on surgical management of primary diffuse type 2‐dominant chronic rhinosinusitis

EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care

European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis

Chronic rhinosinusitis outcome registry (CHRINOSOR) : establishment of an international outcome registry driven by mHealth technology

Omalizumab improves quality of life in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma

COVID-19 and olfactory dysfunction : an ENT perspective to the current COVID-19 pandemic

Omalizumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of asthma status

Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis : an EAACI position paper

Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis : an EAACI position paper (vol 10, 1, 2020)

Real-life assessment of chronic rhinosinusitis patients using mobile technology : the mySinusitisCoach project by EUFOREA

Contents

Support

Contact